U.S. flag

An official website of the United States government

NM_000179.3(MSH6):c.2056G>T (p.Gly686Cys) AND Hereditary nonpolyposis colorectal neoplasms

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Nov 28, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000460149.10

Allele description

NM_000179.3(MSH6):c.2056G>T (p.Gly686Cys)

Gene:
MSH6:mutS homolog 6 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
2p16.3
Genomic location:
Preferred name:
NM_000179.3(MSH6):c.2056G>T (p.Gly686Cys)
HGVS:
  • NC_000002.12:g.47800039G>T
  • NG_007111.1:g.21893G>T
  • NM_000179.3:c.2056G>TMANE SELECT
  • NM_001281492.2:c.1666G>T
  • NM_001281493.2:c.1150G>T
  • NM_001281494.2:c.1150G>T
  • NP_000170.1:p.Gly686Cys
  • NP_000170.1:p.Gly686Cys
  • NP_001268421.1:p.Gly556Cys
  • NP_001268422.1:p.Gly384Cys
  • NP_001268423.1:p.Gly384Cys
  • LRG_219t1:c.2056G>T
  • LRG_219:g.21893G>T
  • LRG_219p1:p.Gly686Cys
  • NC_000002.11:g.48027178G>T
  • NM_000179.2:c.2056G>T
Protein change:
G384C
Links:
dbSNP: rs1060502934
NCBI 1000 Genomes Browser:
rs1060502934
Molecular consequence:
  • NM_000179.3:c.2056G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001281492.2:c.1666G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001281493.2:c.1150G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001281494.2:c.1150G>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Hereditary nonpolyposis colorectal neoplasms
Identifiers:
MeSH: D003123; MedGen: C0009405

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000551251Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Likely pathogenic
(Nov 28, 2023)
germlineclinical testing

PubMed (11)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Feasibility of screening for Lynch syndrome among patients with colorectal cancer.

Hampel H, Frankel WL, Martin E, Arnold M, Khanduja K, Kuebler P, Clendenning M, Sotamaa K, Prior T, Westman JA, Panescu J, Fix D, Lockman J, LaJeunesse J, Comeras I, de la Chapelle A.

J Clin Oncol. 2008 Dec 10;26(35):5783-8. doi: 10.1200/JCO.2008.17.5950. Epub 2008 Sep 22.

PubMed [citation]
PMID:
18809606
PMCID:
PMC2645108

A multifactorial likelihood model for MMR gene variant classification incorporating probabilities based on sequence bioinformatics and tumor characteristics: a report from the Colon Cancer Family Registry.

Thompson BA, Goldgar DE, Paterson C, Clendenning M, Walters R, Arnold S, Parsons MT, Michael D W, Gallinger S, Haile RW, Hopper JL, Jenkins MA, Lemarchand L, Lindor NM, Newcomb PA, Thibodeau SN; Colon Cancer Family Registry., Young JP, Buchanan DD, Tavtigian SV, Spurdle AB.

Hum Mutat. 2013 Jan;34(1):200-9. doi: 10.1002/humu.22213. Epub 2012 Oct 11.

PubMed [citation]
PMID:
22949379
PMCID:
PMC3538359
See all PubMed Citations (11)

Details of each submission

From Invitae, SCV000551251.9

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (11)

Description

This sequence change replaces glycine, which is neutral and non-polar, with cysteine, which is neutral and slightly polar, at codon 686 of the MSH6 protein (p.Gly686Cys). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with MSH6-related conditions. ClinVar contains an entry for this variant (Variation ID: 410509). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt MSH6 protein function with a negative predictive value of 95%. This variant disrupts the p.Gly686 amino acid residue in MSH6. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 18809606, 22949379, 25559809, 26552419, 26681312, 27273229, 28514183, 28531214, 28944238, 31965077; Invitae). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 7, 2024